doc. MUDr. Regina Demlová, Ph.D.
Department head, Department of Pharmacology
Office: bldg. A19/324
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 6526, +420 725 828 385 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 275
2018
-
THE REAL-WORLD COST AND EFFECTIVENESS OF EVEROLIMUS IN METASTATIC BREAST CANCER IN THE CZECH REPUBLIC
Year: 2018, type: Conference abstract
-
Využití MRI ASL metody pro porovnání změn perfuze mozku v různých neurovývojových animálních modelech schizofrenie
Year: 2018, type: Appeared in Conference without Proceedings
2017
-
ANALÝZA NÁKLADŮ NA LÉČBU CETUXIMABEM A PANITUMUMABEM V 1. LINII LÉČBY MCRC
Year: 2017, type: Conference abstract
-
Aripiprazole-induced adverse metabolic alterations in polyI:C neurodevelopmental model of schizophrenia in rats
Neuropharmacology, year: 2017, volume: 123, edition: 1 September 2017, DOI
-
Atezolizumab
Acta medicinae, year: 2017, volume: 71, edition: 11
-
Behaviorální účinky aripiprazolu ve vývojovém modelu schizofrenie
Year: 2017, type: Conference abstract
-
Immunomonitoring of patients treated with personalized dendritic cell-based vaccine
Year: 2017, type: Conference abstract
-
MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9
Oncogenesis, year: 2017, volume: 6, edition: 11, DOI
-
Nežádoucí metabolické účinky aripiprazolu v polyI:C modelu schizofrenie u potkana
Year: 2017, type: Appeared in Conference without Proceedings
-
Predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab
Oncotarget, year: 2017, volume: 8, edition: 61, DOI